Framework of the Bio-Heat Transfer for Laser/Cancer Treatment
Mhamed Nour, Mohammed Bougataya, Emmanuel Kengne, Karim El Guemhioui, and Ahmed Lakhssassi
Université du Québec en Outaouais, Québec, Canada
Abstract—Controlled thermal ablation poses a challenge during a laser surgery/cancer treatment. A software tool would help physicians predict, organize the treatment as well as maximize therapeutic effects while minimizing side effects. This would provide a precise idea of the predicted reaction depending on selected doses, tissue geometry, and the laser source prior to the treatment; so new treatment strategies can be proposed and evaluated. In this paper, we propose a new approach for the laser surgery/cancer treatment with physician interaction. The physician would enter a scenario by selecting the tissue and specifying tissue tumor size, laser type, probe size, laser power, and time range. The model would then automatically generate the Power Deposition Model; select the tissue thermal and optical properties; start the simulation; dynamically update thermal and optical properties; and show the physiological responses. This model shows the impact of the heat distribution and thermal damage to the tissue during the simulation and then allows the physician to adjust the scenario according to the treatment objective. A case study of the Laser Interstitial Thermal Therapy (LITT) will demonstrate the feasibility of the framework.
Index Terms—framework, bio-heat equation, laser source, thermal damage, tissue cancer, bio-heat transfer simulation
Cite: Mhamed Nour, Mohammed Bougataya, Emmanuel Kengne, Karim El Guemhioui, and Ahmed Lakhssassi, "Framework of the Bio-Heat Transfer for Laser/Cancer Treatment," International Journal of Pharma Medicine and Biological Sciences, Vol. 5, No. 4, pp. 194-200, Octorber 2016. doi: 10.18178/ijpmbs.5.4.194-200
Cite: Mhamed Nour, Mohammed Bougataya, Emmanuel Kengne, Karim El Guemhioui, and Ahmed Lakhssassi, "Framework of the Bio-Heat Transfer for Laser/Cancer Treatment," International Journal of Pharma Medicine and Biological Sciences, Vol. 5, No. 4, pp. 194-200, Octorber 2016. doi: 10.18178/ijpmbs.5.4.194-200